SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-12-052888
Filing Date
2012-02-10
Accepted
2012-02-10 17:06:46
Documents
1
Group Members
JACOB GOTTLIEBJG ASSET, LLCLUMX VISIUM CREDIT FUND LTDLYXOR/VISIUM INSTITUTIONAL PARTNERS FUND LTDVISIUM BALANCED MASTER FUND, LTD.VISIUM CATALYST CREDIT MASTER FUND, LTD.VISIUM CREDIT MASTER FUND, LTD.VISIUM GLOBAL MASTER FUND, LTD.VISIUM INSTITUTIONAL P

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO.1 d299412dsc13ga.htm SC 13G/A 290189
  Complete submission text file 0001193125-12-052888.txt   292109
Mailing Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022
Business Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022 646 840 5800
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Subject) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-86354 | Film No.: 12593923
SIC: 2834 Pharmaceutical Preparations